Type 2 Diabetes

Latest News

A Scientific Statement From the AHA on CV Risk in Nonalcoholic Fatty Liver Disease

By

Jessica Nye, PhD

The American Heart Association has issued a scientific statement regarding the relationship between nonalcoholic fatty liver disease and cardiovascular risk.

Maintenance of Intermittent Fasting for Weight Loss and Metabolic Health Improvements

By

Jessica Nye, PhD

A team of investigators evaluated the success of a time-restricted eating intervention among individuals at increased risk of developing type 2 diabetes.

Subjective Cognitive Impairment Associated With Major Adverse CV Events in Patients With T2D

For individuals with type 2 diabetes, subjective cognitive impairment (SCI) is associated with cardiovascular events.

Genetic Mapping Predicts Risk of Cardiovascular Events in People With Type 2 Diabetes

By

Maria Arini Lopez, PT, DPT, CSCS, CMTPT

Researchers report findings from the ACCORD trial that evaluated the relationship of a blood pressure polygenic risk score with cardiovascular outcomes in individuals with type 2 diabetes.

Bariatric Surgery Associated With Remission of Prediabetes and Type 2 Diabetes

By

Jessica Nye, PhD

Investigators assessed outcomes 5 years after bariatric surgery among patients with obesity and type 2 diabetes.

Genetic Risk Scores Predictive of Diabetes Among Youth and Young Adults

By

Jessica Nye, PhD

A team of investigators used genetic risk scores for type 1 diabetes and type 2 diabetes to identify genetic associations across racial and ethnic groups of youth in the United States.

Genomics-Enhanced Risk Tools and Polygenic Risk Scores for Coronary Heart Disease and T2D

By

Ron Goldberg

Investigators evaluated the effect of genomics-enhanced, questionnaire-based risk tools on polygenic risk scores for coronary heart disease and type 2 diabetes.

Achieving Treatment Goals in T2D Can Increase Life Expectancy

Reducing glycated hemoglobin (HbA1c), systolic blood pressure (SBP), low-density lipoprotein cholesterol (LDL-C), and body mass index (BMI) can improve life expectancy (LE) among people with type 2 diabetes (T2D).

Cognitive Behavioral Therapy for Depression Among Patients With Type 2 Diabetes

By

Jessica Nye, PhD

Investigators conducted a scoping review of randomized controlled trials that evaluated the impact of cognitive behavioral therapy on symptoms of depression and anxiety among patients with type 2 diabetes.

RYGB Is Cost-Effective at 5 Years in Patients With Severe Obesity and T2D

By

Colby Stong

Researchers sought to determine the cost-effectiveness of Roux-en-Y gastric bypass, medical therapy, and sleeve gastrectomy in patients with severe obesity and T2D.

Clinical Charts

Insulins

Insulin Administration

Insulin Pen Devices